期刊
CELL METABOLISM
卷 9, 期 6, 页码 512-524出版社
CELL PRESS
DOI: 10.1016/j.cmet.2009.05.005
关键词
-
资金
- SCARTNET
- Swiss University Conference
- Swiss National Science Foundation [3100-063486]
- Gebert Ruf Foundation [P038/01]
- Novartis Foundation grant
- Dr. Josef Steiner Cancer grant
Development of cardiac hypertrophy and progression to heart failure entails profound changes in myocardial metabolism, characterized by a switch from fatty acid utilization to glycolysis and lipid accumulation. We report that hypoxia-inducible factor (HIF)1 alpha and PPAR gamma, key mediators of glycolysis and lipid anabolism, respectively, are jointly upregulated in hypertrophic cardiomyopathy and cooperate to mediate key changes in cardiac metabolism. In response to pathologic stress, HIF1 alpha activates glycolytic genes and PPAR gamma, whose product, in turn, activates fatty acid uptake and glycerolipid biosynthesis genes. These changes result in increased glycolytic flux and glucose-to-lipid conversion via the glycerol-3-phosphate pathway, apoptosis, and contractile dysfunction. Ventricular deletion of Hif1 alpha in mice prevents hypertrophy-induced PPAR-gamma activation, the consequent metabolic reprogramming, and contractile dysfunction. We propose a model in which activation of the HIF1 alpha-PPAR gamma axis by pathologic stress underlies key changes in cell metabolism that are characteristic of and contribute to common forms of heart disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据